The Adaptive designs CONSORT Extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design
出版年份 2020 全文链接
标题
The Adaptive designs CONSORT Extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design
作者
关键词
-
出版物
BMJ-British Medical Journal
Volume -, Issue -, Pages m115
出版商
BMJ
发表日期
2020-06-17
DOI
10.1136/bmj.m115
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Adaptive Design: A Review of the Technical, Statistical, and Regulatory Aspects of Implementation in a Clinical Trial
- (2019) Franck Pires Cerqueira et al. Therapeutic Innovation & Regulatory Science
- A Review of Clinical Trials With an Adaptive Design and Health Economic Analysis
- (2019) Laura Flight et al. VALUE IN HEALTH
- COMPare: a prospective cohort study correcting and monitoring 58 misreported trials in real time
- (2019) Ben Goldacre et al. Trials
- Randomised trials with provision for early stopping for benefit (or harm): The impact on the estimated treatment effect
- (2019) S.D. Walter et al. STATISTICS IN MEDICINE
- Reporting of Multi-Arm Parallel-Group Randomized Trials
- (2019) Edmund Juszczak et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- TAILoR (TelmisArtan and InsuLin Resistance in HIV): An Adaptive Design Dose-Ranging Phase IIb Randomised Trial of Telmisartan for the Reduction of Insulin Resistance in HIV-Positive Individuals on Combination Antiretroviral Therapy
- (2019) Sudeep Pushpakom et al. CLINICAL INFECTIOUS DISEASES
- CONSORT 2010 statement: extension to randomised crossover trials
- (2019) Kerry Dwan et al. BMJ-British Medical Journal
- Adaptive designs in clinical trials: why use them, and how to run and report them
- (2018) Philip Pallmann et al. BMC Medicine
- Evaluation of the extent of adaptation to sample size in clinical trials for cardiovascular and CNS diseases
- (2018) Sue-Jane Wang et al. Contemporary Clinical Trials
- Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct
- (2018) Raul G. Nogueira et al. NEW ENGLAND JOURNAL OF MEDICINE
- Robustness of testing procedures for confirmatory subpopulation analyses based on a continuous biomarker
- (2018) Alexandra Christine Graf et al. STATISTICAL METHODS IN MEDICAL RESEARCH
- Are CONSORT checklists submitted by authors adequately reflecting what information is actually reported in published papers?
- (2018) David Blanco et al. Trials
- Adaptive design clinical trials: a review of the literature and ClinicalTrials.gov
- (2018) Laura E Bothwell et al. BMJ Open
- Key design considerations for adaptive clinical trials: a primer for clinicians
- (2018) Kristian Thorlund et al. BMJ-British Medical Journal
- Key design considerations for adaptive clinical trials: a primer for clinicians
- (2018) Kristian Thorlund et al. BMJ-British Medical Journal
- Critical concepts in adaptive clinical trials
- (2018) Jay JH Park et al. Clinical Epidemiology
- Performance and predictors of recruitment success in National Heart, Lung, and Blood Institute’s cardiovascular clinical trials
- (2018) Victoria L Pemberton et al. Clinical Trials
- Design and estimation in clinical trials with subpopulation selection
- (2018) Yi-Da Chiu et al. STATISTICS IN MEDICINE
- An alternative method to analyse the biomarker-strategy design
- (2018) Cornelia Ursula Kunz et al. STATISTICS IN MEDICINE
- An adaptive population enrichment phase III trial of TRC105 and pazopanib versus pazopanib alone in patients with advanced angiosarcoma (TAPPAS trial)
- (2018) C R Mehta et al. ANNALS OF ONCOLOGY
- Multi-arm multi-stage trials can improve the efficiency of finding effective treatments for stroke: a case study
- (2018) Thomas Jaki et al. BMC Cardiovascular Disorders
- Development process of a consensus-driven CONSORT extension for randomised trials using an adaptive design
- (2018) Munyaradzi Dimairo et al. BMC Medicine
- Statistical testing for baseline differences between randomised groups is not meaningful
- (2018) L. A. Harvey SPINAL CORD
- Reporting quality of randomized controlled trial abstracts in the seven highest-ranking anesthesiology journals
- (2018) Katja Janackovic et al. Trials
- Adaptive designs in clinical trials: from scientific advice to marketing authorisation to the European Medicine Agency
- (2018) Olivier Collignon et al. Trials
- New guidance to improve sample size calculations for trials: eliciting the target difference
- (2018) Melanie L. Bell Trials
- DELTA2 guidance on choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trial
- (2018) Jonathan A Cook et al. BMJ-British Medical Journal
- Adaptive Designs: Results of 2016 Survey on Perception and Use
- (2018) Alan Hartford et al. Therapeutic Innovation & Regulatory Science
- Preoperative chemotherapy versus chemoradiotherapy in locally advanced adenocarcinomas of the oesophagogastric junction (POET): Long-term results of a controlled randomised trial
- (2017) Michael Stahl et al. EUROPEAN JOURNAL OF CANCER
- Guidelines for Statistical Analysis Plans
- (2017) David L. DeMets et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Guidelines for the Content of Statistical Analysis Plans in Clinical Trials
- (2017) Carrol Gamble et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Trends in study design and the statistical methods employed in a leading general medicine journal
- (2017) M. Gosho et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Practical characteristics of adaptive design in phase 2 and 3 clinical trials
- (2017) A. Sato et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Bayesian clinical trial designs
- (2017) Jan O. Jansen et al. Journal of Trauma and Acute Care Surgery
- The Importance of Considering Differences in Study Design in Network Meta-analysis: An Application Using Anti-Tumor Necrosis Factor Drugs for Ulcerative Colitis
- (2017) Chris Cameron et al. MEDICAL DECISION MAKING
- Safety and efficacy of neublastin in painful lumbosacral radiculopathy
- (2017) Miroslav Backonja et al. PAIN
- Accurate p -values for adaptive designs with binary endpoints
- (2017) Stephane Heritier et al. STATISTICS IN MEDICINE
- Point estimation in adaptive enrichment designs
- (2017) Kevin Kunzmann et al. STATISTICS IN MEDICINE
- Inference for multimarker adaptive enrichment trials
- (2017) Richard Simon et al. STATISTICS IN MEDICINE
- Quantifying the bias in the estimated treatment effect in randomized trials having interim analyses and a rule for early stopping for futility
- (2017) S. D. Walter et al. STATISTICS IN MEDICINE
- Adaptive Enrichment Designs for Stroke Clinical Trials
- (2017) Michael Rosenblum et al. STROKE
- On the Optimal Timing of Futility Interim Analyses
- (2017) Dong Xi et al. Statistics in Biopharmaceutical Research
- Estimands and Their Role in Clinical Trials
- (2017) Mouna Akacha et al. Statistics in Biopharmaceutical Research
- Informing efficient randomised controlled trials: exploration of challenges in developing progression criteria for internal pilot studies
- (2017) Kerry N L Avery et al. BMJ Open
- Bayesian clinical trial designs
- (2017) Jan O. Jansen et al. Journal of Trauma and Acute Care Surgery
- Outcome reporting bias in randomized-controlled trials investigating antipsychotic drugs
- (2017) M Lancee et al. Translational Psychiatry
- The role of adaptive trial designs in drug development
- (2017) François Curtin et al. Expert Review of Clinical Pharmacology
- Clinical trial designs incorporating predictive biomarkers
- (2016) Lindsay A. Renfro et al. CANCER TREATMENT REVIEWS
- Bayesian survival analysis in clinical trials: What methods are used in practice?
- (2016) Caroline Brard et al. Clinical Trials
- Quantifying over-estimation in early stopped clinical trials and the “freezing effect” on subsequent research
- (2016) Hao Wang et al. Clinical Trials
- The pragmatic clinical trial in a learning health care system
- (2016) Roger J Lewis Clinical Trials
- Efficiencies of platform clinical trials: A vision of the future
- (2016) Benjamin R Saville et al. Clinical Trials
- Clinical trial design and rationale of the Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) investigational device exemption clinical study protocol
- (2016) Gerald Heatley et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial
- (2016) Nicholas D James et al. LANCET
- Response-adaptive clinical trials: case studies in the medical literature
- (2016) Andrew P. Grieve PHARMACEUTICAL STATISTICS
- A multi-stage drop-the-losers design for multi-arm clinical trials
- (2016) James Wason et al. STATISTICAL METHODS IN MEDICAL RESEARCH
- Attitudes and opinions regarding confirmatory adaptive clinical trials: a mixed methods analysis from the Adaptive Designs Accelerating Promising Trials into Treatments (ADAPT-IT) project
- (2016) William J. Meurer et al. Trials
- Adaptive designs undertaken in clinical research: a review of registered clinical trials
- (2016) Isabella Hatfield et al. Trials
- Addressing Challenges and Opportunities of “Less Well-Understood” Adaptive Designs
- (2016) Weili He et al. Therapeutic Innovation & Regulatory Science
- Adaptive Design Practice at the Center for Devices and Radiological Health (CDRH), January 2007 to May 2013
- (2016) Xiting Yang et al. Therapeutic Innovation & Regulatory Science
- DIA’s Adaptive Design Scientific Working Group (ADSWG)
- (2016) Eva Miller et al. Therapeutic Innovation & Regulatory Science
- Biomarker-Guided Adaptive Trial Designs in Phase II and Phase III: A Methodological Review
- (2016) Miranta Antoniou et al. PLoS One
- Are We There Yet? Early Stopping in Clinical Trials
- (2015) Robert L. Wears ANNALS OF EMERGENCY MEDICINE
- A Bayesian adaptive design for biomarker trials with linked treatments
- (2015) James M S Wason et al. BRITISH JOURNAL OF CANCER
- Sample size adjustment based on promising interim results and its application in confirmatory clinical trials
- (2015) YH Joshua Chen et al. Clinical Trials
- Simulation study for evaluating the performance of response-adaptive randomization
- (2015) Yining Du et al. Contemporary Clinical Trials
- Testing for baseline differences in randomized controlled trials: an unhealthy research behavior that is hard to eradicate
- (2015) Michiel R de Boer et al. International Journal of Behavioral Nutrition and Physical Activity
- The Platform Trial
- (2015) Scott M. Berry et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Methods for identification and confirmation of targeted subgroups in clinical trials: A systematic review
- (2015) Thomas Ondra et al. Journal of Biopharmaceutical Statistics
- Challenging Issues in Clinical Trial Design
- (2015) Stuart J. Pocock et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- A Randomized, Controlled Trial of Oral Propranolol in Infantile Hemangioma
- (2015) Christine Léauté-Labrèze et al. NEW ENGLAND JOURNAL OF MEDICINE
- A surrogate-primary replacement algorithm for response-adaptive randomization in stroke clinical trials
- (2015) Amy S Nowacki et al. STATISTICAL METHODS IN MEDICAL RESEARCH
- Adaptive sample size modification in clinical trials: start small then ask for more?
- (2015) Christopher Jennison et al. STATISTICS IN MEDICINE
- Twenty-five years of confirmatory adaptive designs: opportunities and pitfalls
- (2015) Peter Bauer et al. STATISTICS IN MEDICINE
- No solution yet for combining two independent studies in the presence of heterogeneity
- (2015) Andrea Gonnermann et al. STATISTICS IN MEDICINE
- Missing steps in a staircase: a qualitative study of the perspectives of key stakeholders on the use of adaptive designs in confirmatory trials
- (2015) Munyaradzi Dimairo et al. Trials
- Cross-sector surveys assessing perceptions of key stakeholders towards barriers, concerns and facilitators to the appropriate use of adaptive designs in confirmatory trials
- (2015) Munyaradzi Dimairo et al. Trials
- Adding a treatment arm to an ongoing clinical trial: a review of methodology and practice
- (2015) Dena R Cohen et al. Trials
- Telmisartan and Insulin Resistance in HIV (TAILoR): protocol for a dose-ranging phase II randomised open-labelled trial of telmisartan as a strategy for the reduction of insulin resistance in HIV-positive individuals on combination antiretroviral therapy
- (2015) Sudeep P Pushpakom et al. BMJ Open
- Avoidable waste of research related to inadequate methods in clinical trials
- (2015) Y. Yordanov et al. BMJ-British Medical Journal
- Avoidable waste of research related to inadequate methods in clinical trials
- (2015) Y. Yordanov et al. BMJ-British Medical Journal
- CBER’s Experience With Adaptive Design Clinical Trials
- (2015) Min Lin et al. Therapeutic Innovation & Regulatory Science
- An Investigation of the Shortcomings of the CONSORT 2010 Statement for the Reporting of Group Sequential Randomised Controlled Trials: A Methodological Systematic Review
- (2015) Abigail Stevely et al. PLoS One
- Maximum type 1 error rate inflation in multiarmed clinical trials with adaptive interim sample size modifications
- (2014) Alexandra C. Graf et al. BIOMETRICAL JOURNAL
- Three steps to writing adaptive study protocols in the early phase clinical development of new medicines
- (2014) Ulrike Lorch et al. BMC Medical Research Methodology
- Evaluation of Intravenous Peramivir for Treatment of Influenza in Hospitalized Patients
- (2014) M. D. de Jong et al. CLINICAL INFECTIOUS DISEASES
- A seamless Phase IIB/III adaptive outcome trial: Design rationale and implementation challenges
- (2014) Y H Joshua Chen et al. Clinical Trials
- Dose-finding results in an adaptive, seamless, randomized trial of once-weekly dulaglutide combined with metformin in type 2 diabetes patients (AWARD-5)
- (2014) Z. Skrivanek et al. DIABETES OBESITY & METABOLISM
- Alternative Views On Setting Clinical Trial Futility Criteria
- (2014) Paul Gallo et al. Journal of Biopharmaceutical Statistics
- Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure
- (2014) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Continuous Infusion of Clonidine in Ventilated Newborns and Infants
- (2014) Christoph Hünseler et al. Pediatric Critical Care Medicine
- When is a seamless study desirable? Case studies from different pharmaceutical sponsors
- (2014) Robert L. Cuffe et al. PHARMACEUTICAL STATISTICS
- Flexible sequential designs for multi-arm clinical trials
- (2014) D. Magirr et al. STATISTICS IN MEDICINE
- Adaptive clinical trial designs for European marketing authorization: a survey of scientific advice letters from the European Medicines Agency
- (2014) Amelie Elsäßer et al. Trials
- Safety and Efficacy of Single Dose versus Multiple Doses of AmBisome® for Treatment of Visceral Leishmaniasis in Eastern Africa: A Randomised Trial
- (2014) Eltahir A. G. Khalil et al. PLoS Neglected Tropical Diseases
- Adaptive Design
- (2014) Caroline Claire Morgan et al. Therapeutic Innovation & Regulatory Science
- CONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomized Trials
- (2013) Kenneth F. Schulz ANNALS OF INTERNAL MEDICINE
- Adaptive enrichment with subpopulation selection at interim: Methodologies, applications and design considerations
- (2013) Sue-Jane Wang et al. Contemporary Clinical Trials
- Viscum album [L.] extract therapy in patients with locally advanced or metastatic pancreatic cancer: A randomised clinical trial on overall survival
- (2013) W. Tröger et al. EUROPEAN JOURNAL OF CANCER
- Efficacy and Safety of Crofelemer for Noninfectious Diarrhea in HIV-Seropositive Individuals (ADVENT Trial): A Randomized, Double-Blind, Placebo-Controlled, Two-Stage Study
- (2013) Rodger D. MacArthur et al. HIV CLINICAL TRIALS
- Reporting of Noninferiority and Equivalence Randomized Trials
- (2013) Gilda Piaggio et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Anticoagulation With Otamixaban and Ischemic Events in Non–ST-Segment Elevation Acute Coronary Syndromes
- (2013) Philippe Gabriel Steg JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Optimal Timing for Interim Analyses in Clinical Trials
- (2013) Kanae Togo et al. Journal of Biopharmaceutical Statistics
- A practical guide to Bayesian group sequential designs
- (2013) Thomas Gsponer et al. PHARMACEUTICAL STATISTICS
- Exact inference for adaptive group sequential designs
- (2013) Ping Gao et al. STATISTICS IN MEDICINE
- Impact of lack-of-benefit stopping rules on treatment effect estimates of two-arm multi-stage (TAMS) trials with time to event outcome
- (2013) Babak Choodari-Oskooei et al. Trials
- Similarities and Differences of Bayesian Designs and Adaptive Designs for Medical Devices: A Regulatory View
- (2013) Gregory Campbell Statistics in Biopharmaceutical Research
- Unblinded Adaptive Statistical Information Design Based on Clinical Endpoint or Biomarker
- (2013) Sue-Jane Wang* et al. Statistics in Biopharmaceutical Research
- Selective reporting of outcomes in randomised controlled trials in systematic reviews of cystic fibrosis
- (2013) Kerry Dwan et al. BMJ Open
- Design and rationale of the Treatment of Acute Coronary Syndromes with Otamixaban trial: A double-blind triple-dummy 2-stage randomized trial comparing otamixaban to unfractionated heparin and eptifibatide in non–ST-segment elevation acute coronary syndromes with a planned early invasive strategy
- (2012) Philippe Gabriel Steg et al. AMERICAN HEART JOURNAL
- A generalized Dunnett test for multi-arm multi-stage clinical studies with treatment selection
- (2012) D. Magirr et al. BIOMETRIKA
- Stopping a trial early – and then what?
- (2012) Janet Wittes Clinical Trials
- Overview, hurdles, and future work in adaptive designs: perspectives from a National Institutes of Health-funded workshop
- (2012) Christopher S Coffey et al. Clinical Trials
- Coordinating Data Monitoring Committees and Adaptive Clinical Trial Designs
- (2012) Jay Herson DRUG INFORMATION JOURNAL
- Good Practices for Adaptive Clinical Trials in Pharmaceutical Product Development
- (2012) Brenda Gaydos et al. DRUG INFORMATION JOURNAL
- Vitamin D Therapy and Cardiac Structure and Function in Patients With Chronic Kidney Disease
- (2012) Ravi Thadhani et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Minimizing the Maximum Expected Sample Size in Two-Stage Phase II Clinical Trials with Continuous Outcomes
- (2012) James M. S. Wason et al. Journal of Biopharmaceutical Statistics
- On the Independence of Data Monitoring Committee in Adaptive Design Clinical Trials
- (2012) Shein-Chung Chow et al. Journal of Biopharmaceutical Statistics
- MUltiple Sclerosis and Extract of Cannabis: results of the MUSEC trial
- (2012) John Peter Zajicek et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Group sequential tests for delayed responses (with discussion)
- (2012) Lisa V. Hampson et al. JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY
- Celecoxib plus hormone therapy versus hormone therapy alone for hormone-sensitive prostate cancer: first results from the STAMPEDE multiarm, multistage, randomised controlled trial
- (2012) Nicholas D James et al. LANCET ONCOLOGY
- Some recommendations for multi-arm multi-stage trials
- (2012) James Wason et al. STATISTICAL METHODS IN MEDICAL RESEARCH
- Unplanned adaptations before breaking the blind
- (2012) Martin Posch et al. STATISTICS IN MEDICINE
- Biomarkers and surrogate endpoints in clinical trials
- (2012) Thomas R. Fleming et al. STATISTICS IN MEDICINE
- Optimal design of multi-arm multi-stage trials
- (2012) James M. S. Wason et al. STATISTICS IN MEDICINE
- Flexible trial design in practice - stopping arms for lack-of-benefit and adding research arms mid-trial in STAMPEDE: a multi-arm multi-stage randomized controlled trial
- (2012) Matthew R Sydes et al. Trials
- Adaptive trial designs: a review of barriers and opportunities
- (2012) John A Kairalla et al. Trials
- Consort 2010 statement: extension to cluster randomised trials
- (2012) M. K. Campbell et al. BMJ-British Medical Journal
- Vitamin D Receptor Activation and Left Ventricular Hypertrophy in Advanced Kidney Disease
- (2011) Ravi Thadhani et al. AMERICAN JOURNAL OF NEPHROLOGY
- Group Sequential Methods and Software Applications
- (2011) Li Zhu et al. AMERICAN STATISTICIAN
- The use of group sequential, information-based sample size re-estimation in the design of the PRIMO study of chronic kidney disease
- (2011) Yili Pritchett et al. Clinical Trials
- A 5-week study of the pharmacokinetics and pharmacodynamics of LY2189265, a novel, long-acting glucagon-like peptide-1 analogue, in patients with type 2 diabetes
- (2011) P. Barrington et al. DIABETES OBESITY & METABOLISM
- Benefits, challenges and obstacles of adaptive clinical trial designs
- (2011) Shein-Chung Chow et al. Orphanet Journal of Rare Diseases
- An adaptive confirmatory trial with interim treatment selection: Practical experiences and unbalanced randomization
- (2011) Stephane Heritier et al. STATISTICS IN MEDICINE
- Optimal multistage designs for randomised clinical trials with continuous outcomes
- (2011) James M.S. Wason et al. STATISTICS IN MEDICINE
- Adaptive Methods: When and How Should They be Used in Clinical Trials?
- (2011) Raphaël Porcher et al. THERAPIE
- The BATTLE Trial: Personalizing Therapy for Lung Cancer
- (2011) Edward S. Kim et al. Cancer Discovery
- Once-Daily Bronchodilators for Chronic Obstructive Pulmonary Disease
- (2010) James F. Donohue et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Barriers and opportunities for implementation of adaptive designs in pharmaceutical product development
- (2010) Judith Quinlan et al. Clinical Trials
- A Bayesian adaptive design with biomarkers for targeted therapies
- (2010) Jens C Eickhoff et al. Clinical Trials
- Benefit–risk assessment: the use of clinical utility index
- (2010) Daniele Ouellet Expert Opinion On Drug Safety
- Stopping Randomized Trials Early for Benefit and Estimation of Treatment EffectsSystematic Review and Meta-regression Analysis
- (2010) Dirk Bassler JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Perspectives on the Use of Adaptive Designs in Clinical Trials. Part I. Statistical Considerations and Issues
- (2010) Sue-Jane Wang Journal of Biopharmaceutical Statistics
- A novel adaptive design strategy increases the efficiency of clinical trials in secondary progressive multiple sclerosis
- (2010) Jeremy Chataway et al. Multiple Sclerosis Journal
- An adaptive seamless phase II/III design for oncology trials with subpopulation selection using correlated survival endpoints†
- (2010) Martin Jenkins et al. PHARMACEUTICAL STATISTICS
- Integrating indacaterol dose selection in a clinical study in COPD using an adaptive seamless design
- (2010) Peter J. Barnes et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Testing for qualitative interactions between stages in an adaptive study
- (2010) Robert A. Parker STATISTICS IN MEDICINE
- Adaptive increase in sample size when interim results are promising: A practical guide with examples
- (2010) Cyrus R. Mehta et al. STATISTICS IN MEDICINE
- Guidance for Developers of Health Research Reporting Guidelines
- (2010) David Moher et al. PLOS MEDICINE
- Adaptive Designs for Randomized Trials in Public Health
- (2009) C. Hendricks Brown et al. Annual Review of Public Health
- A systematic review of the reporting of Data Monitoring Committees' roles, interim analysis and early termination in pediatric clinical trials
- (2009) Ricardo M Fernandes et al. BMC Pediatrics
- I-SPY 2: An Adaptive Breast Cancer Trial Design in the Setting of Neoadjuvant Chemotherapy
- (2009) AD Barker et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Futility interim monitoring with control of type I and II error probabilities using the interim Z-value or confidence limit
- (2009) John M Lachin Clinical Trials
- Stopping clinical trials early for benefit: impact on estimation
- (2009) Boris Freidlin et al. Clinical Trials
- Avoidable waste in the production and reporting of evidence
- (2009) Yao-long Chen et al. LANCET
- What should be the role of homogeneity testing in adaptive trials?
- (2009) Paul Gallo et al. PHARMACEUTICAL STATISTICS
- Confirmatory adaptive designs with Bayesian decision tools for a targeted therapy in oncology
- (2009) Werner Brannath et al. STATISTICS IN MEDICINE
- Selection and bias-Two hostile brothers
- (2009) Peter Bauer et al. STATISTICS IN MEDICINE
- Adaptive designs for confirmatory clinical trials
- (2009) Frank Bretz et al. STATISTICS IN MEDICINE
- Exact Confidence Bounds Following Adaptive Group Sequential Tests
- (2008) Werner Brannath et al. BIOMETRICS
- Maintaining confidentiality of interim data to enhance trial integrity and credibility
- (2008) Thomas R Fleming et al. Clinical Trials
- Speeding up the Evaluation of New Agents in Cancer
- (2008) M. K. B. Parmar et al. JNCI-Journal of the National Cancer Institute
- CONSORT for reporting randomised trials in journal and conference abstracts
- (2008) Sally Hopewell et al. LANCET
- Adaptive design methods in clinical trials – a review
- (2008) Shein-Chung Chow et al. Orphanet Journal of Rare Diseases
- Exploring changes in treatment effects across design stages in adaptive trials
- (2008) Tim Friede et al. PHARMACEUTICAL STATISTICS
- Systematic Review of the Empirical Evidence of Study Publication Bias and Outcome Reporting Bias
- (2008) Kerry Dwan et al. PLoS One
- One- and two-stage design proposals for a phase II trial comparing three active treatments with control using an ordered categorical endpoint
- (2008) John Whitehead et al. STATISTICS IN MEDICINE
- Adaptive Clinical Trials
- (2008) Christopher S Coffey et al. Drugs in research & development
- CONSORT for Reporting Randomized Controlled Trials in Journal and Conference Abstracts: Explanation and Elaboration
- (2008) Sally Hopewell et al. PLOS MEDICINE
- Adaptive Dunnett tests for treatment selection
- (2007) Franz Koenig et al. STATISTICS IN MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started